Table 1.
A summary of the different treatment strategies applied in the analyzed study group.
Treatment strategy | Patients |
---|---|
Sildenafil + endothelin receptor antagonist | 14 |
Sildenafil + treprostinil | 3 |
Sildenafil + endothelin receptor antagonist + treprostinil | 3 |
Sildenafil in monotherapy | 2 |
Endothelin receptor antagonist in monotherapy | 2 |
Sildenafil + iloprost | 1 |
Sildenafil + riociguat | 1 |